glp 1 is retatrutide for weight loss: Study shows 30% body weight loss Retatrutide vs Tirzepatide (2026): Differences

GIPR activation enhances adipose tissue lipid buffering, improves beta-cell function, and may amplify central anorectic signaling

Among those who do start using GLP-1s, over 50% stop due to costs, and as many as 36% stop due to side effects

This dual focus is important because it shows that while all doses of retatrutide influenced weight, the degree of improvement in glucose control and lipid profiles did not always track exactly with weight loss

Able to stimulate insulin production in the body, the hormone helps to regulate blood sugar levels and suppress appetite

Cardiometabolic Profiles of Oral and Subcutaneous GLP-1 Receptor Mono-Agonists in Adults With Overweight or Obesity: A Systematic Review and Network Meta-Analysis

Known Side Effects and Risks to Be Aware Of The most common side effects are gastrointestinal including nausea, vomiting, and diarrhoea with additional class-associated risks including pancreatitis, gallbladder disease, and increased heart rate